|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Organovo, Inc.
| | | Phone: | (858) 550-9994 | Year Established: | 2007 | Employees: | 54 | Ticker: | ONVO | Exchange: | NASDAQ | Main Contact: | Taylor J. Crouch, CEO | | Other Contacts: | Paul Gallant, GM Keith Murphy, Chairman Eric Michael David, MD, JD, Chief Strategy Officer Michael Renard, Executive VP, Commercial Operations Sharon Collins Presnell, CTO & Executive VP, R&D Craig Kussman, CFO Steven G. Hughes, CMO
| | Company Description | Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The Company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners. Organovo's 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. The Company’s ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing. The Company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications. In addition to numerous scientific publications, the Company’s technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets. Organovo is changing the shape of life science research and transforming medical care. | |
|
|
|
|
|